- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02020655
Measurement of Cytokines (IL-1α) After Shear- Force Application at the Skin
Background: A pressure ulcer is localized tissue injury to the superficial layer of the skin and/ or the underlying tissue. Pressure ulcers are most likely to develop in skin areas exposed to pressure, shear and friction. Shear- force is an important contributing factor and wound dressing are possibly capable to reduce shear force at the skin. At this moment there's no good marker to detect the effect of shear- force at the skin. A potential marker could be cytokines (IL-1α) which are released after mechanical loading of the skin. A previous study have shown a significant increased level of IL-1α after the application of pressure. We want to investigate if these cytokines are significant increased after the application of shear- force at the skin.
Objective: The objective of this study is to gather knowledge about cytokine concentrations (IL-1 α) in the skin of healthy volunteers after the application of shear- force. We want to use this knowledge in the future to investigate if different prophylactic wound dressings are capable to reduce shear force at the skin. This could be interesting in the prevention of pressure ulcers.
Study design: With the use of a special developed shear- force model are we going to administer 20 Newton (2 kg) shear at the palmar side of the under arm in 10 healthy volunteers for 30 minutes. As a control we ware going to put the shear- force model at the other arm without the application of shear- force. Before the use of the shear- force model we will perform cytokine measurements with the use of Sebutape. Sebutape is capable to absorb cytokines from the skin. After the use of the shear force- model we will perform cytokine measurements again. Then we will extract the cytokines from the Sebutape with the use of ELISA.
Study population: 10 Healthy volunteers Age 18- 30 years
Primary outcome: IL-1 α concentration (pg/ml)
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Limburg
-
Maastricht, Limburg, Nederland, 6229 HX
- Maastricht University Medical Centre
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age 18- 30 years
- BMI 20 -30
- Braden score > 20
Exclusion Criteria:
- Trauma arms
- Skin diseases (eczema, psoriasis)
- Inability to give informed consent
- Muscle disorders
- malignancy
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
10 healthy volunteers
Shear- force model
|
Shear- force model
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
IL-1 α concentration (pg/ml)
Tijdsspanne: up to 24 hours
|
With the use of a special developed shear- force model are we going to administer 20 Newton (2 kg) shear at the palmar side of the under arm in 10 healthy volunteers for 30 minutes.
As a control we ware going to put the shear- force model at the other arm without the application of shear- force.
Before the use of the shear- force model we will perform cytokine measurements with the use of Sebutape.
Sebutape is capable to absorb cytokines from the skin.
After the use of the shear force- model we will perform cytokine measurements again.
|
up to 24 hours
|
Medewerkers en onderzoekers
Onderzoekers
- Studie stoel: Nicole Bouvy, MD, PhD, Department of surgery, Maastricht University Medical Centre
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- NL46877.068.13
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Shear- force model
-
Mayo ClinicWervingAdemhalingscomplicatie | AdemhalingsfunctieverliesVerenigde Staten
-
Vejle HospitalVoltooidRectale neoplasmata | ElasticiteitsbeeldvormingstechniekenDenemarken
-
Ramzy Raafat Mohamed Mohamed Elnabarawy, MD, MSc...Cairo UniversityVoltooidOm de waarde van peniselastografie bij de diagnose van fibrose van CC te onderzoekenEgypte
-
University Of PerugiaOnbekendErectiestoornissen | Ziekten van de penisItalië
-
Trakya UniversityOnbekend
-
University of DundeeVoltooid
-
University of Southern CaliforniaNational Cancer Institute (NCI)VoltooidBot sarcoom | Retroperitoneaal sarcoom | Wekedelensarcoom bij volwassenenVerenigde Staten
-
Istanbul UniversityVoltooidPatellaire tendinopathieKalkoen
-
Assistance Publique - Hôpitaux de ParisVoltooidIntensive Care-afdeling | Ventilator spenenFrankrijk
-
Fábio FernandesPfizerOnbekend